首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1859700

細胞治療處理：全球市場與技術

Cell Therapy Processing: Global Markets and Technologies

出版日期: 2025年10月30日 | 出版商:

BCC Research | 英文 125 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球細胞治療處理市場預計將從2025年的27億美元成長到2030年的71億美元，2025年至2030年的年複合成長率為 21.4%。

預計北美市場將從2025年的12億美元成長到2030年的33億美元，2025年至2030年的年複合成長率為22.2%。預計亞太市場將從2025年的5.687億美元成長到2030年的18億美元，2025年至2030年的年複合成長率為25.5%。

本報告調查全球細胞治療處理市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測，以及按各個細分市場和地區進行的詳細分析。

市場動態
市場促進因素
對再生醫學的需求日益成長
加大細胞和基因治療（CGT）研究的投資
拓展臨床和商業活動
加強策略性舉措
人口老化和慢性病增加
市場限制
複雜製造與供應鏈
高昂的開發成本
熟練勞動力短缺
監管障礙
市場機會
分散式製造
過渡到同種異體療法

第4章監理現狀

概述
各國的監管情景
美國食品藥物管理局
歐洲
亞太地區

第5章新興科技與發展

重點總結
自動化
第一代自動化平台
第二代自動化平台
一次性技術和小型化

第6章市場區隔分析

概述
細分市場分析
市場分析：依產品類型
重點總結
產品
服務
軟體
市場分析：依應用領域
重點總結
癌症
肌肉骨骼疾病（骨骼和骨骼肌修復）
神經系統疾病
心血管疾病
其他
地理細分
市場分析：依地區
重點總結
北美洲
歐洲
亞太地區
其他地區

第7章競爭訊息

重點總結
競爭分析
策略舉措
協議、合作與夥伴關係
獲得
投資與擴張

第8章細胞治療處理市場的永續性：ESG視角

ESG簡介
細胞治療處理產業的永續性
環境因素
社會因素
管治因素
ESG永續發展趨勢與舉措
環境績效
社會表現
管治績效
ESG風險評估
結論

第9章附錄

調查方法
資訊來源
簡稱
公司簡介
BIO-TECHNE
BIOSPHERIX LLC.
CYTIVA
FRESENIUS KABI AG
FUJIFILM BIOSCIENCES
LONZA
MERCK KGAA
MILTENYI BIOTEC
PROTEINTECH GROUP INC.
REVVITY
SARTORIUS AG
STEMCELL TECHNOLOGIES
TERUMO CORP.
THERMO FISHER SCIENTIFIC INC.
THERMOGENESIS
Start-Ups創業公司/市場顛覆者

簡介目錄圖表

Product Code: BIO160B

The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030.

The North American market for cell therapy processing is estimated to grow from $1.2 billion in 2025 to reach $3.3 billion by 2030, at a CAGR 22.2% from 2025 to 2030.

The Asia-Pacific market for cell therapy processing is estimated to grow from $568.7 million in 2025 to reach $1.8 billion by 2030, at a CAGR 25.5% from 2025 to 2030.

Report Scope

The report provides an overview of global cell therapy processing and analyzes market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025 with forecasts through 2030. The market is segmented based on offering type, application and regions. By offering, the market is segmented into products, software and services. By application, the market is segmented into cancer, musculoskeletal disorders, neurological disorders, cardiovascular diseases and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East, Africa, and South America, focusing on the major countries in these regions. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, and the Rest of Asia-Pacific.

The report focuses on the significant driving trends and challenges that affect the market. It analyzes environmental, social and corporate governance (ESG) developments. It includes an analysis of the competitive landscape and has a dedicated section of company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.

Report Includes

32 data tables and 58 additional tables
An overview of the global market and technologies for cell therapy processing
In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
Evaluation of the current market size and revenue growth prospects specific to the cell therapy processing, accompanied by a market share analysis by offerings, application and region
Analysis of current and future demand in the global cell therapy processing market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
Analysis of drivers, challenges and opportunities affecting market growth
Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
Market share analysis of the key market participants in the cell therapy processing market, along with their research priorities, product portfolios, global rankings and company competitive landscape
Profiles of the major companies, including Thermo Fisher Scientific Inc., Danaher Corp., Lonza, Miltenyi Biotech and Sartorius AG

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Market Insights
Emerging Technologies
Conclusion

Chapter 2 Market Overview

Overview
Cell Therapy Manufacturing Process
Cell Therapy Supply Chain
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of U.S. Tariffs
Porter's Five Forces Analysis

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Growing Demand for Regenerative Medicine
Increasing Investments in Cell and Gene Therapy (CGT) Research
Expanding Clinical and Commercial Activities
Growing Number of Strategic Initiatives
Rising Aging Population and the Increasing Prevalence of Chronic Diseases
Market Restraints
Complex Manufacturing and Supply Chain
High Cost of Development
Lack of Skilled Workforce
Regulatory Hurdles
Market Opportunities
Decentralized Manufacturing
Shift Toward Allogeneic Therapies

Chapter 4 Regulatory Landscape

Overview
Regulatory Scenario by Country/Region
U.S. FDA
Europe
Asia-Pacific

Chapter 5 Emerging Technologies and Developments

Key Takeaways
Automation
First-Generation Automated Platforms
Second-Generation Automated Platforms
Single-Use Technologies and Miniaturization

Chapter 6 Market Segment Analysis

Overview
Segmentation Breakdown
Market Analysis by Type of Offerings
Key Takeaways
Products
Services
Software
Market Analysis by Application
Key Takeaways
Cancer
Musculoskeletal Disorders (Bone and Skeletal Muscle Repair)
Neurological Disorders
Cardiovascular Disorders
Others
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 Competitive Intelligence

Key Takeaways
Competitive Analysis
Strategic Initiatives
Agreements, Collaborations and Partnerships
Acquisitions
Investments and Expansions

Chapter 8 Sustainability in Cell Therapy Processing Market: An ESG Perspective

Introduction to ESG
Sustainability in the Cell Therapy Processing Industry
Environmental Factors
Social Factors
Governance Factors
ESG Sustainability Trends and Initiatives
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks

Chapter 9 Appendix

Research Methodology
Information Sources
Abbreviations
Company Profiles
BIO-TECHNE
BIOSPHERIX LLC.
CYTIVA
FRESENIUS KABI AG
FUJIFILM BIOSCIENCES
LONZA
MERCK KGAA
MILTENYI BIOTEC
PROTEINTECH GROUP INC.
REVVITY
SARTORIUS AG
STEMCELL TECHNOLOGIES
TERUMO CORP.
THERMO FISHER SCIENTIFIC INC.
THERMOGENESIS
Emerging Start-ups/Market Disruptors

簡介目錄圖表

List of Tables

Summary Table : Global Market for Cell Therapy Processing, by Region, Through 2030
Table 1 : Classification of Stem Cells
Table 2 : Incidence and Mortality Rates of Cancer Across Regions, 2022
Table 3 : Comparison Between Autologous and Allogeneic Therapeutics
Table 4 : Regulations for Advanced Therapies in the Asia-Pacific Region
Table 5 : Global Market for Cell Therapy Processing, by Offering, Through 2030
Table 6 : Global Market for Cell Therapy Processing Products, by Region, Through 2030
Table 7 : Global Market for Cell Therapy Processing Services, by Region, Through 2030
Table 8 : Global Market for Cell Therapy Processing Software, by Region, Through 2030
Table 9 : Global Market for Cell Therapy Processing, by Application, Through 2030
Table 10 : Global Market for Cell Therapy Processing for Oncology, by Region, Through 2030
Table 11 : Global Market for Cell Therapy Processing for Musculoskeletal Disorders, by Region, Through 2030
Table 12 : Global Market for Cell Therapy Processing for Neurological Disorders, by Region, Through 2030
Table 13 : Global Market for Cell Therapy Processing for Cardiovascular Disorders, by Region, Through 2030
Table 14 : Global Market for Cell Therapy Processing for Other Disease Indications, by Region, Through 2030
Table 15 : Global Market for Cell Therapy Processing, by Region, Through 2030
Table 16 : North American Market for Cell Therapy Processing, by Offering, Through 2030
Table 17 : North American Market for Cell Therapy Processing, by Application, Through 2030
Table 18 : North American Market for Cell Therapy Processing, by Country, Through 2030
Table 19 : European Market for Cell Therapy Processing, by Offering, Through 2030
Table 20 : European Market for Cell Therapy Processing, by Application, Through 2030
Table 21 : European Market for Cell Therapy Processing, by Country, Through 2030
Table 22 : Asia-Pacific Market for Cell Therapy Processing, by Offering, Through 2030
Table 23 : Asia-Pacific Market for Cell Therapy Processing, by Application, Through 2030
Table 24 : Asia-Pacific Market for Cell Therapy Processing, by Country, Through 2030
Table 25 : RoW Market for Cell Therapy Processing, by Offering, Through 2030
Table 26 : RoW Market for Cell Therapy Processing, by Application, Through 2030
Table 27 : RoW Market for Cell Therapy Processing, by Sub-Region, Through 2030
Table 28 : Global Ranking of Players: Cell Therapy Processing Market, 2024
Table 29 : Agreements, Collaborations and Partnerships: Cell Therapy Processing Market, 2021-2025
Table 30 : Acquisitions: Cell Therapy Processing Market, 2022-2025
Table 31 : VC Investments and Expansion Activities: Cell Therapy Processing Market, 2022-2025
Table 32 : ESG: Environmental Overview
Table 33 : ESG: Social Overview
Table 34 : ESG: Governance Overview
Table 35 : ESG Risk Rankings for Cell Therapy Processing Market Companies, 2025
Table 36 : Information Sources in this Report
Table 37 : Abbreviations Used in the Cell Therapy Processing Market Report
Table 38 : Bio-Techne: Company Snapshot
Table 39 : Bio-Techne: Financial Performance, FY 2023 and 2024
Table 40 : Bio-Techne: Product Portfolio
Table 41 : Bio-Techne: News/Key Developments, 2022-2025
Table 42 : BioSpherix LLC.: Company Snapshot
Table 43 : BioSpherix LLC.: Product Portfolio
Table 44 : BioSpherix LLC.: News/Key Developments, 2022-2025
Table 45 : Cytiva.: Company Snapshot
Table 46 : Cytiva: Product Portfolio
Table 47 : Cytiva: News/Key Developments, 2021-2024
Table 48 : Fresenius Kabi AG: Company Snapshot
Table 49 : Fresenius Kabi AG: Financial Performance, FY 2023 and 2024
Table 50 : Fresenius Kabi AG: Product Portfolio
Table 51 : Fresenius Kabi AG: News/Key Developments, 2022-2024
Table 52 : Fujifilm Biosciences: Company Snapshot
Table 53 : Fujifilm Biosciences: Product Portfolio
Table 54 : Fujifilm Biosciences: News/Key Developments, 2022-2025
Table 55 : Lonza: Company Snapshot
Table 56 : Lonza: Financial Performance, FY 2023 and 2024
Table 57 : Lonza: Product Portfolio
Table 58 : Lonza: News/Key Developments, 2021-2024
Table 59 : Merck KGaA: Company Snapshot
Table 60 : Merck KGaA.: Financial Performance, FY 2023 and 2024
Table 61 : Merck KGaA: Product Portfolio
Table 62 : Merck KGaA.: News/Key Developments, 2021-2025
Table 63 : Miltenyi Biotec: Company Snapshot
Table 64 : Miltenyi Biotec: Product Portfolio
Table 65 : Miltenyi Biotec: News/Key Developments, 2023-2024
Table 66 : Proteintech Group Inc.: Company Snapshot
Table 67 : Proteintech Group Inc.: Product Portfolio
Table 68 : Revvity: Company Snapshot
Table 69 : Revvity: Financial Performance, FY 2023 and 2024
Table 70 : Revvity: Product Portfolio
Table 71 : Revvity: News/Key Developments, 2024 and 2025
Table 72 : Sartorius AG: Company Snapshot
Table 73 : Sartorius AG: Financial Performance, FY 2023 and 2024
Table 74 : Sartorius AG: Product Portfolio
Table 75 : Sartorius AG: News/Key Developments, 2023-2024
Table 76 : STEMCELL Technologies: Company Snapshot
Table 77 : STEMCELL Technologies: Product Portfolio
Table 78 : STEMCELL Technologies: News/Key Developments, 2022-2025
Table 79 : Terumo Corp.: Company Snapshot
Table 80 : Terumo Corp.: Financial Performance, FY 2023 and 2024
Table 81 : Terumo Corp.: Product Portfolio
Table 82 : Terumo Corp.: News/Key Developments, 2021-2025
Table 83 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 84 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 85 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 86 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2025
Table 87 : ThermoGenesis: Company Snapshot
Table 88 : ThermoGenesis: Product Portfolio
Table 89 : List of a Few Emerging Startups in the Cell Therapy Processing Market

List of Figures

Summary Figure : Global Market Shares of Cell Therapy Processing, by Region, 2024
Figure 1 : Porter's Five Forces Analysis of the Cell Therapy Processing Market
Figure 2 : Snapshot of the Market Dynamics for Cell Therapy Processing
Figure 3 : CGT Market Investments, by Year, 2019-2024
Figure 4 : CGT Market Investments, by Deal Type, H1 2025
Figure 5 : Global Market Shares of Cell Therapy Processing, by Offering Type, 2024
Figure 6 : Global Market Shares of Cell Therapy Processing, by Application, 2024
Figure 7 : Global Market Shares of Cell Therapy Processing, by Region, 2024
Figure 8 : North American Market Shares of Cell Therapy Processing, by Country, 2024
Figure 9 : European Market Shares of Cell Therapy Processing, by Country, 2024
Figure 10 : Asia-Pacific Market Shares of Cell Therapy Processing, by Country, 2024
Figure 11 : RoW Market Shares of Cell Therapy Processing, by Sub-Region, 2024
Figure 12 : Bio-Techne: Revenue Share, by Business Unit, FY 2024
Figure 13 : Bio-Techne: Revenue Share, by Country/Region, FY 2024
Figure 14 : Fresenius Kabi AG: Revenue Share, by Business Unit, FY 2024
Figure 15 : Lonza: Revenue Share, by Business Unit, FY 2024
Figure 16 : Lonza: Revenue Share, by Country/Region, FY 2024
Figure 17 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
Figure 18 : Merck KGaA.: Revenue Share by Country/Region, FY 2024
Figure 19 : Revvity: Revenue Share, by Business Unit, FY 2024
Figure 20 : Revvity: Revenue Share, by Country/Region, FY 2024
Figure 21 : Sartorius AG: Revenue Share, by Business Unit, FY 2024
Figure 22 : Sartorius AG: Revenue Share, by Country/Region, FY 2024
Figure 23 : Terumo Corp.: Revenue Share, by Business Unit, FY 2024
Figure 24 : Terumo Corp.: Revenue Share, by Country/Region, FY 2024
Figure 25 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 26 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024